Den Europæiske Union - dansk - EMA (European Medicines Agency)

sanofi b.v. - avalglucosidase alfa - glycogen opbevaring sygdom type ii - andre alimentary tract and metabolism produkter, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).

Den Europæiske Union - dansk - EMA (European Medicines Agency)

sun pharmaceutical industries (europe) b.v. - ertapenemnatrium - bakterieinfektioner - ertapenem - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4. 4 og 5. 1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4. 4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..

Den Europæiske Union - dansk - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - multipel sklerose, recidiverende-remitterende - immunosuppressiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - esomeprazolnatrium - pulver til injektions-/infusionsvæske, opløsning - 40 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - natriumnitroprussiddihydrat - pulver til infusionsvæske, opløsning - 60 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

jubilant pharmaceuticals nv - rubidium (82-rb) chlorid, strontium (82sr) chlorid - radionuklidgenerator - 3,7 gbq

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - solifenacinsuccinat, tamsulosinhydrochlorid - tabletter med modificeret udløsning - 6+0,4 mg